UroPartners Revenue and Competitors

USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • UroPartners's estimated annual revenue is currently $81.4M per year.(i)
  • UroPartners's estimated revenue per employee is $297,000

Employee Data

  • UroPartners has 274 Employees.(i)
  • UroPartners grew their employee count by 6% last year.

UroPartners's People

NameTitleEmail/Phone
1
Chief Radiation TherapistReveal Email/Phone
2
Chief Radiation TherapistReveal Email/Phone
3
Chief Radiation TherapistReveal Email/Phone
4
ControllerReveal Email/Phone
5
Laboratory Medical DirectorReveal Email/Phone
6
Physician, medical directorReveal Email/Phone
7
Chief Medical Information OfficerReveal Email/Phone
8
Senior Director Revenue Cycle OperationsReveal Email/Phone
9
Director In-Office DispensaryReveal Email/Phone
10
Practice ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$66.2M22320%N/AN/A
#2
$7.3M346%N/AN/A
#3
$217.7M64527%N/AN/A
#4
$129.6M38410%N/AN/A
#5
$15.1M6222%N/AN/A
#6
$42.8M14415%N/AN/A
#7
$110.8M32313%$117MN/A
#8
$103.2M3012%$440.7KN/A
#9
$107.3M31810%N/AN/A
#10
$46.9M15834%N/AN/A
Add Company

What Is UroPartners?

UroPartners is an extensive network of physician practices with locations throughout Chicagoland. The physicians of UroPartners are all board-certified specialists in urology whose skill and expertise combine to provide today’s most innovative treatments for urological disorders.\r\n\r\nLike us on Facebook at https://www.facebook.com/pages/UroPartners-LLC/118894771458385

keywords:N/A

N/A

Total Funding

274

Number of Employees

$81.4M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

UroPartners News

2022-03-30 - United States Clinical Laboratory Services Market Growth ...

... Cleveland Clinic (Hospital-based Laboratory); UroPartners (POL); Care Mount Medical (Physician Owned Laboratory).

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$63.3M274N/AN/A
#2
$74.1M2746%N/A
#3
$81.4M2746%N/A
#4
$15M274N/AN/A
#5
N/A274N/AN/A